論文・総説 - 末永　光邦

分割表示  324 件中 181 - 200 件目  ／  全件表示 >>

  1. Ohhara Yoshihito, Matsusaka Satoshi, Shinozaki Eiji, Suenaga Mitsukuni, Mizunuma Nobuyuki, Hatake Kiyohiko, Yamaguchi Toshiharu. Circulating tumor cells as predictive marker in panitumumab after progression of cetuximab in Japanese patients with KRAS wild-type metastatic colorectal cancer JOURNAL OF CLINICAL ONCOLOGY. 2013.02; 31 (4):

  2. Watanabe Toshiyasu, Kijima Sho, Goto Mayu, Koiso Yasuhiro, Kawagoe Naoyuki, Takemoto Ikutaka, Maeda Tadashi, Miyazaki Taito, Kido Hidenori, Honda Yoshiko, Kikuchi Yoshinori, Ogura Mariko, Koike Junichi, Shinozaki Eiji, Suenaga Mitsukuni, Matsusaka Satoshi, Funahashi Kimihiko, Shimada Nagato, Nakajima Hitoshi, Urita Yosihisa, Shimada Hiedeaki, Kaneko Hironori, Mizunuma Nobuyuki, Sugimoto Motonobu. Hemodialysis improves 5-FU induced hypreanmonemia with depressed level of conciousness with during 5-FU containing regimen for colon cancer JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2012.12; 27 336-337.

  3. Suenaga M., Matsusaka S., Shinozaki E., Ozaka M., Ogura M., Chin K., Hatake K., Mizunuma N., Yamaguchi T.. A PHASE I/II STUDY OF BI-WEEKLY XELIRI PLUS BEVACIZUMAB FOR PATIENT WITH METASTATIC COLORECTAL CANCER AS SECOND-LINE CHEMOTHERAPY (BIXER STUDY): REPORTS OF INTERIM ANALYSIS OF PHASE II PART ANNALS OF ONCOLOGY. 2012.10; 23 130-131.

  4. Inoue D., Chin K., Ohara K., Takagi K., Ozaka M., Ogura M., Suenaga M., Shinozaki E., Matsusaka S., Mizunuma N., Hatake K.. ABSENCE OF LIVER METASTASIS, LYMPH NODE METASTASIS AND PERITONEAL METASTASIS PREDICT LONGER PROGRESSION FREE SURVIVAL BY S-1 PLUS CISPLATIN TREATMENT IN ADVANCED GASTRIC CANCER ANNALS OF ONCOLOGY. 2012.10; 23 99.

  5. Kawakami K., Nakamoto E., Yokokawa T., Mae Y., Sugita K., Suenaga M., Mizunuma N., Yamaguchi T., Hama T.. COMPLIANCE WITH CAPECITABINE ON XELOX TREATMENT ANNALS OF ONCOLOGY. 2012.10; 23 129.

  6. Matsusaka S., Chin K., Ogur M., Shinozaki E., Suenaga M., Mizunuma N., Sano T., Yamaguchi T., Hatake K.. DETECTION AND HER2 EXPRESSION OF CIRCULATING TUMOR CELLS IN ADVANCED GASTRIC CANCER PATIENTS ANNALS OF ONCOLOGY. 2012.10; 23 118.

  7. Matsusaka S., Kuboki Y., Suenaga M., Shinozaki E., Mizunuma N., Hatake K.. CIRCULATING TUMOR CELLS AS A PROGNOSTIC MARKER IN ADVANCE COLORECTAL CANCER PATIENTS TREATED WITH CETUXIMAB-CONTAINING SALVAGE CHEMOTHERAPY ANNALS OF ONCOLOGY. 2012.09; 23 87.

  8. Tsushima Takahiro, Taguri Masataka, Honma Yoshitaka, Takahashi Hideaki, Ueda Shinya, Nishina Tomohiro, Kawai Hiroki, Kato Shunsuke, Suenaga Mitsukuni, Tamura Fumio, Morita Satoshi, Boku Narikazu. Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy ONCOLOGIST. 2012.09; 17 (9): 1163-1170. ( PubMed, DOI )

  9. Suenaga Mitsukuni, Mizunuma Nobuyuki, Fujimoto Yoshiya, Ueno Masashi, Matsusaka Satoshi, Shinozaki Eiji, Fukunaga Yosuke, Nagayama Satoshi, Yamaguchi Toshiharu. A phase II study of perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01): Report of interim analysis. JOURNAL OF CLINICAL ONCOLOGY. 2012.05; 30 (15):

  10. Matsusaka Satoshi, Chin Keisho, Ogura Mariko, Suenaga Mitsukuni, Shinozaki Eiji, Mizunuma Nobuyuki, Sano Takeshi, Yamaguchi Toshiharu, Yamamoto Noriko, Ishikawa Yuichi, Mishima Yuji, Terui Yasuhito, Hatake Kiyohiko. Detection and HER2 expression of circulating tumor cells in advanced gastric cancer patients JOURNAL OF CLINICAL ONCOLOGY. 2012.05; 30 (15):

  11. Ito Yoshinori, Suenaga Mitsukuni, Hatake Kiyohiko, Takahashi Shunji, Yokoyama Masahiro, Onozawa Yusuke, Yamazaki Kentaro, Hironaka Shuichi, Hashigami Kiyoshi, Hasegawa Hirotaka, Takenaka Nobuko, Boku Narikazu. Safety, Efficacy and Pharmacokinetics of Neratinib (HKI-272) in Japanese Patients with Advanced Solid Tumors: A Phase 1 Dose-escalation Study JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2012.04; 42 (4): 278-286. ( PubMed, DOI )

  12. Ito Yoshinori, Suenaga Mitsukuni, Hatake Kiyohiko, Takahashi Shunji, Yokoyama Masahiro, Onozawa Yusuke, Yamazaki Kentaro, Hironaka Shuichi, Hashigami Kiyoshi, Hasegawa Hirotaka, Takenaka Nobuko, Boku Narikazu. 進行固形腫瘍の日本人患者におけるneratinib(HKI-272)の安全性、有効性および薬物動態　第I相用量漸増試験(Safety, Efficacy and Pharmacokinetics of Neratinib (HKI-272) in Japanese Patients with Advanced Solid Tumors: A Phase 1 Dose-escalation Study) Japanese Journal of Clinical Oncology. 2012.04; 42 (4): 278-286. ( 医中誌 )

  13. Suenaga Mitsukuni, Matsusaka Satoshi, Shinozaki Eiji, Mizunuma Nobuyuki, Hatake Kiyohiko, Yamaguchi Toshiharu. A phase I/II study of biweekly XELIRI plus bevacizumab for patients with metastatic colorectal cancer as second-line chemotherapy (BIXER study): Reports of phase I part and interim analysis of phase II part. JOURNAL OF CLINICAL ONCOLOGY. 2012.02; 30 (4): ( DOI )

  14. Suenaga Mitsukuni, Matsusaka Satoshi, Mizunuma Nobuyuki, Shinozaki Eiji, Ogura Mariko, Ozaka Masato, Takagi Koichi, Yamaguchi Toshiharu, Hatake Kiyohiko. Addition of bevacizumab to first-line FOLFOX4 and overall survival in patients with metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2012.02; 30 (4): ( DOI )

  15. Inoue Dai, Matsusaka Satoshi, Yamamoto Noriko, Suenaga Mitsukuni, Mishima Yuji, Shinozaki Eiji, Terui Yasuhito, Mizunuma Nobuyuki, Ishikawa Yuichi, Hatake Kiyohiko. CD133 status influences in prognosis of patients with metastatic colorectal cancer receiving cetuximab. JOURNAL OF CLINICAL ONCOLOGY. 2012.02; 30 (4): ( DOI )

  16. Ohhara Yoshihito, Suenaga Mitsukuni, Matsusaka Satoshi, Shinozaki Eiji, Mizunuma Nobuyuki, Yamaguchi Toshiharu, Hatake Kiyohiko. Comparison between the three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2012.02; 30 (4): ( DOI )

  17. Matsusaka Satoshi, Suenaga Mitsukuni, Mishima Yuji, Terui Yasuhito, Shinozaki Eiji, Mizunuma Nobuyuki, Hatake Kiyohiko. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2012.02; 30 (4): ( DOI )

  18. Watanabe Toshiyasu, Shinozaki Eiji, Kijima Sho, Ohhara Yoshihito, Kuboki Yasutoshi, Takagi Koichi, Ozaka Masato, Ogura Mariko, Kikuchi Yoshinori, Suenaga Mitsukuni, Chin Keisho, Matsusaka Satoshi, Koike Junichi, Funahashi Kimihiko, Urita Yoshihisa, Mizunuma Nobuyuki, Hatake Kiyohiko, Kaneko Hironori, Sugimoto Motonobu. Does panitumumab have a clinical benefit in cetuximab-refractory KRAS wild-type metastatic colorectal cancer? JOURNAL OF CLINICAL ONCOLOGY. 2012.02; 30 (4): ( DOI )

  19. Shinozaki Eiji, Yamamoto Noriko, Chin Keisho, Ogura Mariko, Suenaga Mitsukuni, Matsusaka Satoshi, Mizunuma Nobuyuki, Yamaguchi Toshiharu, Hatake Kiyohiko. How many biopsy fragments will be necessary to assess HER2 status for gastric cancer? JOURNAL OF CLINICAL ONCOLOGY. 2012.02; 30 (4): ( DOI )

  20. Kawakami Kazuyoshi, Suenaga Mitsukuni, Yokokawa Takashi, Sugita Kazuo, Mae Yutaro, Nakamoto Eri, Imada Hiroshi, Mizunuma Nobuyuki, Yamaguchi Toshiharu, Hama Toshihiro. Effect of moisturizers on prevention of hand-foot syndrome associated with capecitabine plus oxaliplatin. JOURNAL OF CLINICAL ONCOLOGY. 2012.02; 30 (4): ( DOI )

< 前のページ - 次のページ >

このページの先頭へ▲